Mohammad Kalim Ahmad Khan Selected Research

emiglitate

2/2022

Identifying the alpha-glucosidase inhibitory potential of dietary phytochemicals against diabetes mellitus type 2 via molecular interactions and dynamics simulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohammad Kalim Ahmad Khan Research Topics

Disease

1	Type 2 Diabetes Mellitus (MODY) 02/2022

Drug/Important Bio-Agent (IBA)

1	galactomannanIBA 02/2022
1	genkwaninIBA 02/2022
1	caffeic acidIBA 02/2022
1	miglitol (Glyset)FDA Link 02/2022
1	emiglitateIBA 02/2022
1	4,5-dimethyl-3-hydroxy-2(5H)-furanone (sotolone)IBA 02/2022
1	isoimperatorinIBA 02/2022
1	aromadedrin (dihydrokaempferol)IBA 02/2022
1	voglibose (Basen)IBA 02/2022
1	neohesperidinIBA 02/2022
1	AcidsIBA 02/2022
1	alpha-Glucosidases (Acid Maltase)IBA 02/2022
1	Bromelains (Bromelain)IBA 02/2022
1	Cholecalciferol (Vitamin D3)FDA Link 02/2022
1	Insulin (Novolin)FDA Link 02/2022
1	Proteins (Proteins, Gene)FDA Link 02/2022
1	QuercetinIBA 02/2022
1	Quinic Acid (Quinate)IBA 02/2022
1	1-Deoxynojirimycin (1 Deoxynojirimycin)IBA 02/2022
1	Acarbose FDA LinkGeneric 02/2022
1	ApigeninIBA 02/2022
1	LuteolinIBA 02/2022
1	PhytochemicalsIBA 02/2022